593 related articles for article (PubMed ID: 24366528)
21. Therapeutic reduction of GGGGCC repeat RNA levels by hnRNPA3 suppresses neurodegeneration in Drosophila models of C9orf72-linked ALS/FTD.
Taminato T; Takeuchi T; Ueyama M; Mori K; Ikeda M; Mochizuki H; Nagai Y
Hum Mol Genet; 2023 May; 32(10):1673-1682. PubMed ID: 36611007
[TBL] [Abstract][Full Text] [Related]
22. Expression of C9orf72-related dipeptides impairs motor function in a vertebrate model.
Swaminathan A; Bouffard M; Liao M; Ryan S; Callister JB; Pickering-Brown SM; Armstrong GAB; Drapeau P
Hum Mol Genet; 2018 May; 27(10):1754-1762. PubMed ID: 29528390
[TBL] [Abstract][Full Text] [Related]
23. GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport.
Freibaum BD; Lu Y; Lopez-Gonzalez R; Kim NC; Almeida S; Lee KH; Badders N; Valentine M; Miller BL; Wong PC; Petrucelli L; Kim HJ; Gao FB; Taylor JP
Nature; 2015 Sep; 525(7567):129-33. PubMed ID: 26308899
[TBL] [Abstract][Full Text] [Related]
24. A C9ORF72 BAC mouse model recapitulates key epigenetic perturbations of ALS/FTD.
Esanov R; Cabrera GT; Andrade NS; Gendron TF; Brown RH; Benatar M; Wahlestedt C; Mueller C; Zeier Z
Mol Neurodegener; 2017 Jun; 12(1):46. PubMed ID: 28606110
[TBL] [Abstract][Full Text] [Related]
25. RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention.
Donnelly CJ; Zhang PW; Pham JT; Haeusler AR; Mistry NA; Vidensky S; Daley EL; Poth EM; Hoover B; Fines DM; Maragakis N; Tienari PJ; Petrucelli L; Traynor BJ; Wang J; Rigo F; Bennett CF; Blackshaw S; Sattler R; Rothstein JD
Neuron; 2013 Oct; 80(2):415-28. PubMed ID: 24139042
[TBL] [Abstract][Full Text] [Related]
26. Insights into disease mechanisms and potential therapeutics for C9orf72-related amyotrophic lateral sclerosis/frontotemporal dementia.
Gagliardi D; Costamagna G; Taiana M; Andreoli L; Biella F; Bersani M; Bresolin N; Comi GP; Corti S
Ageing Res Rev; 2020 Dec; 64():101172. PubMed ID: 32971256
[TBL] [Abstract][Full Text] [Related]
27. UBQLN2-HSP70 axis reduces poly-Gly-Ala aggregates and alleviates behavioral defects in the C9ORF72 animal model.
Zhang K; Wang A; Zhong K; Qi S; Wei C; Shu X; Tu WY; Xu W; Xia C; Xiao Y; Chen A; Bai L; Zhang J; Luo B; Wang W; Shen C
Neuron; 2021 Jun; 109(12):1949-1962.e6. PubMed ID: 33991504
[TBL] [Abstract][Full Text] [Related]
28. Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features.
Shaw MP; Higginbottom A; McGown A; Castelli LM; James E; Hautbergue GM; Shaw PJ; Ramesh TM
Acta Neuropathol Commun; 2018 Nov; 6(1):125. PubMed ID: 30454072
[TBL] [Abstract][Full Text] [Related]
29. C9ORF72 hexanucleotide repeat exerts toxicity in a stable, inducible motor neuronal cell model, which is rescued by partial depletion of Pten.
Stopford MJ; Higginbottom A; Hautbergue GM; Cooper-Knock J; Mulcahy PJ; De Vos KJ; Renton AE; Pliner H; Calvo A; Chio A; Traynor BJ; Azzouz M; Heath PR; ; Kirby J; Shaw PJ
Hum Mol Genet; 2017 Mar; 26(6):1133-1145. PubMed ID: 28158451
[TBL] [Abstract][Full Text] [Related]
30. The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions.
Simón-Sánchez J; Dopper EG; Cohn-Hokke PE; Hukema RK; Nicolaou N; Seelaar H; de Graaf JR; de Koning I; van Schoor NM; Deeg DJ; Smits M; Raaphorst J; van den Berg LH; Schelhaas HJ; De Die-Smulders CE; Majoor-Krakauer D; Rozemuller AJ; Willemsen R; Pijnenburg YA; Heutink P; van Swieten JC
Brain; 2012 Mar; 135(Pt 3):723-35. PubMed ID: 22300876
[TBL] [Abstract][Full Text] [Related]
31. Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons.
Almeida S; Gascon E; Tran H; Chou HJ; Gendron TF; Degroot S; Tapper AR; Sellier C; Charlet-Berguerand N; Karydas A; Seeley WW; Boxer AL; Petrucelli L; Miller BL; Gao FB
Acta Neuropathol; 2013 Sep; 126(3):385-99. PubMed ID: 23836290
[TBL] [Abstract][Full Text] [Related]
32. Sense-encoded poly-GR dipeptide repeat proteins correlate to neurodegeneration and uniquely co-localize with TDP-43 in dendrites of repeat-expanded C9orf72 amyotrophic lateral sclerosis.
Saberi S; Stauffer JE; Jiang J; Garcia SD; Taylor AE; Schulte D; Ohkubo T; Schloffman CL; Maldonado M; Baughn M; Rodriguez MJ; Pizzo D; Cleveland D; Ravits J
Acta Neuropathol; 2018 Mar; 135(3):459-474. PubMed ID: 29196813
[TBL] [Abstract][Full Text] [Related]
33. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport.
Zhang K; Donnelly CJ; Haeusler AR; Grima JC; Machamer JB; Steinwald P; Daley EL; Miller SJ; Cunningham KM; Vidensky S; Gupta S; Thomas MA; Hong I; Chiu SL; Huganir RL; Ostrow LW; Matunis MJ; Wang J; Sattler R; Lloyd TE; Rothstein JD
Nature; 2015 Sep; 525(7567):56-61. PubMed ID: 26308891
[TBL] [Abstract][Full Text] [Related]
34. Enhanced insulin signalling ameliorates C9orf72 hexanucleotide repeat expansion toxicity in
Atilano ML; Grönke S; Niccoli T; Kempthorne L; Hahn O; Morón-Oset J; Hendrich O; Dyson M; Adams ML; Hull A; Salcher-Konrad MT; Monaghan A; Bictash M; Glaria I; Isaacs AM; Partridge L
Elife; 2021 Mar; 10():. PubMed ID: 33739284
[TBL] [Abstract][Full Text] [Related]
35. Frontotemporal lobar dementia and amyotrophic lateral sclerosis associated with c9orf72 expansion.
Le Ber I
Rev Neurol (Paris); 2015; 171(6-7):475-81. PubMed ID: 26032484
[TBL] [Abstract][Full Text] [Related]
36. RNA-mediated toxicity in C9orf72 ALS and FTD.
McEachin ZT; Parameswaran J; Raj N; Bassell GJ; Jiang J
Neurobiol Dis; 2020 Nov; 145():105055. PubMed ID: 32829028
[TBL] [Abstract][Full Text] [Related]
37. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS.
Mori K; Weng SM; Arzberger T; May S; Rentzsch K; Kremmer E; Schmid B; Kretzschmar HA; Cruts M; Van Broeckhoven C; Haass C; Edbauer D
Science; 2013 Mar; 339(6125):1335-8. PubMed ID: 23393093
[TBL] [Abstract][Full Text] [Related]
38. C9orf72 Hexanucleotide Expansions Are Associated with Altered Endoplasmic Reticulum Calcium Homeostasis and Stress Granule Formation in Induced Pluripotent Stem Cell-Derived Neurons from Patients with Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
Dafinca R; Scaber J; Ababneh N; Lalic T; Weir G; Christian H; Vowles J; Douglas AG; Fletcher-Jones A; Browne C; Nakanishi M; Turner MR; Wade-Martins R; Cowley SA; Talbot K
Stem Cells; 2016 Aug; 34(8):2063-78. PubMed ID: 27097283
[TBL] [Abstract][Full Text] [Related]
39. Circadian sleep/wake-associated cells show dipeptide repeat protein aggregates in C9orf72-related ALS and FTLD cases.
Dedeene L; Van Schoor E; Vandenberghe R; Van Damme P; Poesen K; Thal DR
Acta Neuropathol Commun; 2019 Dec; 7(1):189. PubMed ID: 31791419
[TBL] [Abstract][Full Text] [Related]
40. Hexanucleotide Repeat Expansions in c9FTD/ALS and SCA36 Confer Selective Patterns of Neurodegeneration In Vivo.
Todd TW; McEachin ZT; Chew J; Burch AR; Jansen-West K; Tong J; Yue M; Song Y; Castanedes-Casey M; Kurti A; Dunmore JH; Fryer JD; Zhang YJ; San Millan B; Teijeira Bautista S; Arias M; Dickson D; Gendron TF; Sobrido MJ; Disney MD; Bassell GJ; Rossoll W; Petrucelli L
Cell Rep; 2020 May; 31(5):107616. PubMed ID: 32375043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
